EUVIMEDEUVIMED entdecken
Crossref

Role of tumor markers and cytokines in the pathogenesis of lung cancer

Maria Tariq, Aqsa Sattar, Amber Khalid, Minahil Azam, Mehak Mehmood, Ramsha Hafeez, Saira Rafaqat

World Journal of Clinical Oncology · 24.06.2026 · 17 (6)

DOI: 10.5306/wjco.121169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.06.2026. Verfasst von Maria Tariq und 6 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is characterized by the uncontrolled proliferation of abnormal cells in one or both lungs, typically originating from the epithelial lining of the airways. Cytokines are small, biologically active proteins that function as signaling molecules, mediating communication between cells and regulating immune and inflammatory responses. In the context of lung cancer, cytokines play a crucial role in modulating the tumor microenvironment and influencing immune responses against malignant cells. Tumor markers and inflammatory cytokines are key contributors to the pathogenesis of lung cancer, facilitating tumor initiation, angiogenesis, and disease progression within an inflammatory microenvironment. Numerous tumor markers and cytokines have been identified and investigated in relation to lung cancer development and progression. However, we focused on carcinoembryonic antigen, squamous cell carcinoma, cytokeratin 19 fragment, tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor, interferon-γ, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, monocyte chemoattractant protein-1 and neuron-specific enolase in the pathogenesis of lung cancer. Furthermore, they promote immune evasion, epithelial-mesenchymal transition, and metastatic dissemination, thereby serving as important diagnostic, prognostic, and therapeutic targets. These biologically active molecules can modulate the immune response, enhancing the body’s ability to inhibit tumor growth and promote the destruction of lung cancer cells. By stimulating immune effector mechanisms and regulating signaling pathways involved in tumor progression, cytokine-based therapies contribute to improved anti-tumor immunity and represent promising strategies in the management of lung cancer.

Zitieren

APA

Tariq, M., Sattar, A., Khalid, A., Azam, M., Mehmood, M., Hafeez, R., & Rafaqat, S. (2026). Role of tumor markers and cytokines in the pathogenesis of lung cancer. World Journal of Clinical Oncology, 17(6). https://doi.org/10.5306/wjco.121169

Vancouver

Tariq M, Sattar A, Khalid A, Azam M, Mehmood M, Hafeez R, et al. Role of tumor markers and cytokines in the pathogenesis of lung cancer. World Journal of Clinical Oncology. 2026;17(6). doi:10.5306/wjco.121169

BibTeX
@article{Tariq2026,
  author = {Tariq, Maria and Sattar, Aqsa and Khalid, Amber and Azam, Minahil and Mehmood, Mehak and Hafeez, Ramsha and Rafaqat, Saira},
  title = {Role of tumor markers and cytokines in the pathogenesis of lung cancer},
  journal = {World Journal of Clinical Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  doi = {10.5306/wjco.121169}
}
Kostenlos starten →